Nanomaterials for Drug Delivery and Neurological Diseases Management [electronic resource] / edited by Santosh Kumar Rath, Vagish Dwibedi, Azamal Husen, Nadeem Akhtar.
Material type:
TextSeries: Smart Nanomaterials TechnologyPublisher: Singapore : Springer Nature Singapore : Imprint: Springer, 2024Edition: 1st ed. 2024Description: XX, 413 p. 46 illus., 44 illus. in color. online resourceContent type: - text
- computer
- online resource
- 9789819703081
- RA1270.N36
- R857.N34
Nanomaterials and Nanocarriers: Basic Properties -- Inorganic, Organic and Polymer-Based Nanomaterials -- Fundamentals of Drug Delivery -- Smart development of nanomaterials and Nanomedicine Formulations -- Nanomaterials and Neurological Disorders Management -- Nanoparticle-based treatment of Central Nervous System (CNS) Diseases -- Nanomaterials for diagnosis and treatment of common neurological disorders -- Biodegradable Nanocarries and disease management -- Targeted nano based drug delivery in Alzheimer's Disease and Dementia -- Nanomaterials as drug delivery vehicles for therapy of Parkinson's Disease -- The use of microbial nanoparticle to treat neurodegenerative disorders -- Aspects of nanomedicines' safety and nanotoxicity for brain-targeted drug delivery.
This book gives a complete overview of current developments in the nano drug delivery technology in the management of neurological disorders and brain diseases. The book is divided into three main sub-sections: A) Fundamental study on nanomaterials, nanocarriers, and nanoformulation-based drug delivery in neurological diseases management, B) Nano drug delivery therapy - a novel approach towards common neurological disorders and C) Novel nano delivery strategies in targeted neurological diseases management. This collective work presents diverse nano-based drug delivery technologies that are high-throughput, reliable, pioneering, and applicable to researchers of different countries despite their socio-economic conditions. It hopefully encourages researchers, innovators and policymaker to adapt nanomaterial-based drug delivery vehicles technologies using diverse nano-based formulation techniques as targeted therapy for treating and managing neurological disorders.
There are no comments on this title.
